Advertorial: Introducing Tor-Bac
Alison Stevenson, Managing Director and Head of R&D at Tor-Bac, explains why this single-dose product has experienced year-on-year sales growth since its introduction to the UK market in 2018. Stevenson
Alison Stevenson, Managing Director and Head of R&D at Tor-Bac, explains why this single-dose product has experienced year-on-year sales growth since its introduction to the UK market in 2018. Stevenson
Alison Stevenson, managing director of manufacturer Tor Generics Ltd, introduces the new single-dose bacteriostatic saline solution Practitioners offering injectable procedures are familiar with using bacteriostatic saline to reconstitute medicinal products for intramuscular or intradermal injection. Tor-bac, a preserved saline solution, …